17.33
-0.28(-1.59%)
Currency In CNY
Sector
Healthcare
Industry
Medical - Devices
Employees
4809
First IPO Date
March 19, 2012
| Name | Title | Pay | Year Born |
| Mr. Baishen Ouyang | Chairman of the Supervisory Board & Assistant to the GM | 0 | 1978 |
| Mr. Zhuzi He | Financial Director | 0 | 1974 |
| Ms. Jiyun Zheng | Deputy GM & Board Secretary | 0 | 1987 |
| Mr. Chungeng Chen | Supervisor & Supply Chain Director | 0 | 1977 |
| Huiyu Xu | Securities Affairs Representative | 0 | N/A |
| Bo Tan | Accounting Supervisor | 0 | N/A |
| Mr. Shao Bo Li | Chairman & GM | 0 | 1965 |
| Mr. Jianwen Cai | Deputy General Manager | 0 | 1974 |
| Mr. Shi Min Wang | Deputy General Manager | 0 | 1969 |
Sinocare Inc. engages in the development, manufacture, and marketing of diagnosis rapid testing products primarily in the People's Republic of China. It offers SARS-CoV-2 antibody test strip; Safe-Accu blood glucose monitoring systems; Safe-AQ blood glucose monitoring systems; Gold-Accu blood glucose monitoring systems; Safe-Accu UG blood, glucose, and uric acid monitoring systems; Safe-Accu KG blood, glucose, and ketone monitoring systems; and D Nurse mobile glucose meters. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products to 135 countries. Sinocare Inc. was founded in 2002 and is based in Changsha, the People's Republic of China.
